CB
WST icon

CNB Bank’s West Pharmaceutical WST Stock Holding History

CNB Bank’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32K Hold
89
– – 0.01% 348
2026
Q1 		$22.3K Sell
89
-12
-12% -$2.99K 0.01% 377
2025
Q4 		$27.8K Hold
101
– – 0.01% 349
2025
Q3 		$26.5K Sell
101
-15
-13% -$3.65K 0.01% 340
2025
Q2 		$25.4K Sell
116
-25
-18% -$5.34K 0.01% 302
2025
Q1 		$31.6K Sell
141
-32
-18% -$8.82K 0.02% 274
2024
Q4 		$56.7K Sell
173
-94
-35% -$29.6K 0.03% 226
2024
Q3 		$80.1K Sell
267
-974
-78% -$298K 0.04% 214
2024
Q2 		$409K Buy
1,241
+56
+5% +$19.8K 0.2% 116
2024
Q1 		$469K Buy
1,185
+213
+22% +$78.8K 0.23% 108
2023
Q4 		$342K Buy
972
+349
+56% +$124K 0.18% 123
2023
Q3 		$234K Buy
623
+128
+26% +$49.5K 0.14% 144
2023
Q2 		$189K Buy
495
+96
+24% +$34.3K 0.11% 152
2023
Q1 		$138K Buy
+399
New +$117K 0.08% 164

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

CNB Bank's WST Position: Q2 2026 in Review

CNB Bank held its West Pharmaceutical (WST) position steady in Q2 2026 at 89 shares worth $32K. The position accounts for 0.01% of the portfolio, ranked #348.

CNB Bank first reported a position in WST in Q1 2023 and has held it in 14 quarters since. The position peaked at $469K in Q1 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • CNB Bank held 89 shares of West Pharmaceutical worth $32K as of Q2 2026.
  • CNB Bank left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up 0.01% of CNB Bank's portfolio in Q2 2026, its #348 holding.
  • CNB Bank first reported a position in West Pharmaceutical in Q1 2023 and has held it in 14 quarters since.
  • CNB Bank's West Pharmaceutical position peaked at $469K in Q1 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on CNB Bank's 13F filing for Q2 2026, filed 6 Aug 2026.